Protective effect of andrographolide against ulcerative colitis by activating Nrf2/HO-1 mediated antioxidant response
Frontiers in Pharmacology · 29.07.2024 · 15
DOI: 10.3389/fphar.2024.1424219 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 29.07.2024. Verfasst von Long Shu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Nutrition, Zhejiang Hospital, Hangzhou, China. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Ulcerative colitis (UC) is a recurring inflammatory bowel disease, in which oxidative stress plays a role in its progression, and regulation of the oxidative/antioxidative balance has been suggested as a potential target for the treatment of UC. The aim of this study was to evaluate the protective effect of andrographolide against UC and its potential antioxidant properties by modulating the nuclear factor erythroid 2-related factor 2 (Nrf2)/heme oxygenase-1 (HO-1) pathway. Dextran sulfate sodium (DSS) -induced UC mice and the LPS-induced HT29 inflammatory cell model were established to uncover the potential mechanisms of andrographolide. ML385, a Nrf2 inhibitor, was used in both models to assess whether andrographolide exerts a protective effect against UC through the Nrf2/HO-1 pathway. The in vivo experiment showed that andrographolide ameliorated the symptoms and histopathology of DSS-induced mice and restored the expressions of ZO-1, Occludin-1 and Claudin-1. Meanwhile, DSS-induced oxidative stress and inflammation were suppressed by andrographolide treatment, along with the upregulation of key proteins in the Nrf2/HO-1 pathway. In vitro experiments showed that andrographolide attenuated LPS-induced excessive generation of ROS in HT29 cells, reduced inflammatory factors, and upregulated the expression of proteins related to tight junctions and Nrf2/HO-1 pathway. In addition, ML385 abolished the beneficial effect of andrographolide. In conclusion, the protective effect of andrographolide against UC may involve the suppression of oxidative stress and inflammation via the Nrf2/HO-1 pathway.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Nutrition, Zhejiang Hospital, Hangzhou, China.
- School of Public Health, Zhejiang Chinese Medical University, Hangzhou, China.
- Department of Digestion, Zhejiang Hospital, Hangzhou, China.
- Academy of Chinese Medical Sciences, Zhejiang Chinese Medical University, Hangzhou, China.
Zitieren
APA
Shu, L., Fu, H., Pi, A., Feng, Y., Dong, H., Si, C., Li, S., Zhu, F., Zheng, P., & Zhu, Q. (2024). Protective effect of andrographolide against ulcerative colitis by activating Nrf2/HO-1 mediated antioxidant response. Frontiers in Pharmacology, 15. https://doi.org/10.3389/fphar.2024.1424219
Vancouver
Shu L, Fu H, Pi A, Feng Y, Dong H, Si C, et al. Protective effect of andrographolide against ulcerative colitis by activating Nrf2/HO-1 mediated antioxidant response. Frontiers in Pharmacology. 2024;15. doi:10.3389/fphar.2024.1424219
BibTeX
@article{Shu2024,
author = {Shu, Long and Fu, Hangjie and Pi, Aiwen and Feng, Yuliang and Dong, Hui and Si, Caijuan and Li, Songtao and Zhu, Feiye and Zheng, Peifen and Zhu, Qin},
title = {Protective effect of andrographolide against ulcerative colitis by activating Nrf2/HO-1 mediated antioxidant response},
journal = {Frontiers in Pharmacology},
year = {2024},
volume = {15},
doi = {10.3389/fphar.2024.1424219}
}
EUVIMED